Results 181 to 190 of about 87,373 (338)

Antibody combining sites can be mimicked synthetically. Surface-simulation synthesis of the phosphorylcholine-combining site of myeloma protein M-603 [PDF]

, 1980
A. Latif Kazim, M. Zouhair Atassi
openalex   +1 more source

A case of visceral leishmaniasis mimicking connective tissue disease

Rheumatology &Autoimmunity, EarlyView.
Yucui Li, Hongxia Yang, Tingzi Zhao, Ke Xu, Liyun Zhang   +4 more
wiley   +1 more source

Screening for monoclonal gammopathy of undetermined significance is contraindicated

British Journal of Haematology, EarlyView.
Incidence of multiple myeloma is about 1.8/100 000. About 3%–5% of adults >50 years of age are diagnosed with monoclonal gammopathy of undetermined significance (MGUS). The prevalence is higher if diagnosis is based on an abnormal ratio of serum free light chains.
Gurmukh Singh
wiley   +1 more source

Research progress on N6-methyladenosine and non-coding RNA in multiple myeloma. [PDF]

Discov Oncol
Sun X, Zhou Y, Zhu W, Chen H.
europepmc   +1 more source

Mapping VEXAS‐associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population

British Journal of Haematology, EarlyView.
VEXAS syndrome is a late‐onset inflammatory disorder with rheumatological and haematological features. Epidemiological studies of VEXAS syndrome so far have been limited. Analysis of various UK cohorts estimates the incidence of VEXAS to be 1.51/100 000, or 171 new cases in the population of men over the age of 50 who are being investigated for myeloid
Ana Martinez Rodriguez, Leon Chang, Dorota Rowczenio, Alexandra Smith, Ebun Omoyinmi, James A. Poulter, Andrew McGregor, Sebastian Francis, Roochi Trikha, Adam Al‐Hakim, Kar Lok Kong, David G. Kent, Helen Lachmann, Austin Kulasekararaj, Catherine Cargo, Sinisa Savic   +15 more
wiley   +1 more source

Decoding multiple myeloma: single-cell insights into tumor heterogeneity, immune dynamics, and disease progression. [PDF]

Front Immunol
Zhao Z, Zhao Z, Lin Z, Fan L, Xiahou Z, Dong Y, Bao W.   +6 more
europepmc   +1 more source

Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH− subgroup of multiple myeloma [PDF]

, 2000
Tomasz Szczepański, Mars B. van ’t Veer, Ingrid L. M. Wolvers‐Tettero, Anton W. Langerak, Jacques J. M. van Dongen   +4 more
openalex   +2 more sources

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments] [PDF]

, 1993
PR Greipp, JA Lust, O'Fallon Wm, JA Katzmann, TE Witzig, RA Kyle   +5 more
openalex   +1 more source

Matrix metalloproteinase inhibition protects against junctophilin‐2 proteolysis during doxorubicin‐induced cardiotoxicity

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Treatment of cancer patients with anthracyclines is known to cause dose‐dependent cardiotoxicity through several mechanisms including enhanced oxidative stress, ultimately resulting in defective excitation–contraction coupling.
Wesam Bassiouni, Brandon Y. H. Chan, Andrej Roczkowsky, Joshua W. Kranrod, Zabed Mahmud, Joseph O. Primeau, Woo Jung Cho, Howard S. Young, John M. Seubert, Richard Schulz   +9 more
wiley   +1 more source

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system [PDF]

, 1992
Régis Bataille, Mario Boccadoro, Bernard Klein, BrianG.M. Durie, Alessandro Pileri   +4 more
openalex   +1 more source